| Status: Excluded due to NICE appraisal | |
Product meets AWMSG exclusion criteria due to NICE appraisal ID6170: Efanesoctocog alfa for treating and preventing bleeding episodes in haemophilia A |
|
Medicine details |
|
| Medicine name | efanesoctocog alfa (ALTUVOCT) |
| Formulation | 250 IU, 500 IU, 750 IU, 1000 IU, 2000 IU, 3000 IU, 4000 IU powder and solvent for solution for injection |
| Reference number | 5159 |
| Indication | Treatment and prophylaxis of bleeding episodes in haemophilia A |
| Company | Swedish Orphan Biovitrum Ltd |
| BNF chapter | Nutrition & blood |
| Submission type | N/A |
| Status | Excluded due to NICE appraisal |
| Date of issue | 20/02/2025 |
| NICE guidance | ID6170: Efanesoctocog alfa for treating and preventing bleeding episodes in haemophilia A |